MONOPAR THERAPEUTICS INC(NASDAQ:MNPR) stock News

MNPR Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Monopar Therapeutics Inc.

Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025

10 days ago - By: Monopar Therapeutics Inc.

Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025

12 days ago - By: Benzinga - Mentions: NTST GHRS NTSK WBI

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

a month ago - By: Benzinga - Mentions: CME UNFI VRTX FCX ...

CrowdStrike To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday

a month ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

a month ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

a month ago - By: Monopar Therapeutics Inc.

Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients

a month ago - By: Monopar Therapeutics Inc.

Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients

a month ago - By: Investor's Business Daily

Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout

a month ago - By: Monopar Therapeutics Inc.

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

2 months ago - By: Monopar Therapeutics Inc.

Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting

a month ago - By: Monopar Therapeutics Inc.

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

2 months ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments

2 months ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments

5 months ago - By: Monopar Therapeutics Inc.

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

5 months ago - By: Monopar Therapeutics Inc.

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

5 months ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

5 months ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

5 months ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

6 months ago - By: Monopar Therapeutics Inc.

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

6 months ago - By: Monopar Therapeutics Inc.

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

6 months ago - By: Yahoo Finance - Mentions: NUTX CMRX FITB MASS ...

Why Nutex Health Inc. (NUTX) is Surging in 2025

6 months ago - By: Yahoo Finance - Mentions: AGL CMRX SYY FITB ...

Why agilon health, inc. (AGL) is Surging in 2025

6 months ago - By: Yahoo Finance - Mentions: TLSA PHH ATPC AGL ...

Why Tiziana Life Sciences Ltd (TLSA) is Surging in 2025

6 months ago - By: Yahoo Finance - Mentions: PVLA TIGO SYY AGL ...

Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025

6 months ago - By: Yahoo Finance - Mentions: DERM NVCT CMRX MASS

Why Journey Medical Corporation (DERM) is Surging in 2025

6 months ago - By: Monopar Therapeutics Inc.

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

6 months ago - By: Monopar Therapeutics Inc.

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

7 months ago - By: Monopar Therapeutics Inc.

Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments

7 months ago - By: Monopar Therapeutics Inc.

Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments

10 months ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

10 months ago - By: Monopar Therapeutics Inc.

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

a year ago - By: Monopar Therapeutics Inc.

Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu

a year ago - By: Monopar Therapeutics Inc.

Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu

a year ago - By: Monopar Therapeutics Inc.

Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference

a year ago - By: Monopar Therapeutics Inc.

MONOPAR THERAPEUTICS INC (MNPR) Stock News

MNPR Latest News, Press Relases and Analysis